Virus Diseases: all 927 studies
Page 2 of 10. Open to participants first (112), then studies with results posted, then the rest; newest registration first within each.
- Impact of Early Lung Physiology, Viral Infections and the Microbiota on the Development and Progression of Lung Disease in Children With Cystic FibrosisRecruitingNCT04026360
- TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.RecruitingNCT04013802Phase 1
- HSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsRecruitingNCT03911388Phase 1
- Hepatitis B Virus Infection After Liver Transplantation in ChildrenRecruitingNCT03865966
- Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological MalignanciesRecruitingNCT03818334Phase 2/3
- Third Party Viral Specific T-cells (VSTs)RecruitingNCT02532452Phase 2
- Donor-Derived Viral Specific T-cells (VSTs)RecruitingNCT02048332Phase 1/2
- A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®RecruitingNCT02007356Phase 2
- Viral Infections in Healthy and Immunocompromised HostsRecruitingNCT01306084
- The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known ImmunocompromiseRecruitingNCT01011712
- Genetic Studies of Chronic Active Epstein-Barr DiseaseRecruitingNCT00032513
- Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and CancerRecruitingNCT00006518
- Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)CompletedNCT06729606Phase 3Results posted
- Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)CompletedNCT06729593Phase 3Results posted
- Stellate Ganglion Block for COVID-induced ParosmiaCompletedNCT06253806Phase 2Results posted
- VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1CompletedNCT06214052Phase 2Results posted
- A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial VirusCompletedNCT06097299Phase 2Results posted
- A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of AgeCompletedNCT06097273Phase 3Results posted
- Safety, Pharmacokinetics,and Antiviral Activity of RV299 Against Respiratory Syncytical Virus (RSV)CompletedNCT06067191Phase 1Results posted
- A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of AgeCompletedNCT06060457Phase 3Results posted
- mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) InterventionCompletedNCT06059443Not applicableResults posted
- A Study to Evaluate the Relative Bioavailability of Subcutaneous Bepirovirsen When Delivered From a Vial or Prefilled Syringe Fitted With a Safety Syringe Device in Healthy Adult ParticipantsCompletedNCT06058390Phase 1Results posted
- Study of mRNA-1010 Seasonal Influenza Vaccine in AdultsCompletedNCT05827978Phase 3Results posted
- A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy AdultsCompletedNCT05827926Phase 1/2Results posted
- A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19CompletedNCT05815498Phase 3Results posted
- Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral TherapyTerminatedNCT05717400Phase 4Results posted
- Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in InfantsTerminatedNCT05584202Phase 2Results posted
- Safety, Tolerability and Prophylactic Antiviral Activity of Neumifil Against Influenza Via a Human Viral Challenge ModelCompletedNCT05507567Phase 2Results posted
- Urgent Care Management of Respiratory Illness Enabled With Novel Testing PathwayCompletedNCT05467007Not applicableResults posted
- HPV Self-Sampling in Somali Women (Isbaar Project)CompletedNCT05453006Not applicableResults posted
- A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or UnprimedCompletedNCT05422326Phase 2Results posted
- A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of AgeCompletedNCT05330975Phase 3Results posted
- Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell TransplantTerminatedNCT05305040Phase 2/3Results posted
- A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult ParticipantsActive, not recruitingNCT05217641Phase 1Results posted
- Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy ParticipantsCompletedNCT05166421Phase 1Results posted
- A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine BoostersCompletedNCT05137236Phase 2Results posted
- A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of AgeCompletedNCT05127434Phase 2/3Results posted
- Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 PatientsTerminatedNCT05077969Phase 2Results posted
- Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19CompletedNCT05054114Not applicableResults posted
- Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]-PF-07304814 in Healthy ParticipantsCompletedNCT05050682Phase 1Results posted
- Adherence to Care for Children With Congenital Zika Virus Infection in Puerto RicoCompletedNCT05041439Not applicableResults posted
- A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus InfectionTerminatedNCT05005507Phase 2Results posted
- A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) InfectionTerminatedNCT04978337Phase 2Results posted
- Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ TransplantTerminatedNCT04933968Phase 1/2Results posted
- Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years OldCompletedNCT04918771Phase 3Results posted
- Zinc and Green Tea Extract for Community Respiratory Viral InfectionsTerminatedNCT04898023Phase 2Results posted
- COmmunity Patients at Risk of Viral Infections Including SARS-CoV-2TerminatedNCT04858451Phase 2Results posted
- ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19CompletedNCT04843761Phase 3Results posted
- Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy AdultsCompletedNCT04786444Phase 3Results posted
- Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in MenCompletedNCT04772469Not applicableResults posted
- A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy AdultsCompletedNCT04758962Phase 1Results posted
- Ad26.ZEBOV Booster in Children Previously Vaccinated With Ad26.ZEBOV and MVA-BN-Filo (EBOVAC Booster Study)CompletedNCT04711356Phase 2Results posted
- Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell TransplantCompletedNCT04693637Phase 2/3Results posted
- Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza.CompletedNCT04682444Phase 2/3Results posted
- Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy SubjectsCompletedNCT04671017Phase 1/2Results posted
- A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus InfectionCompletedNCT04667104Phase 2Results posted
- Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)TerminatedNCT04664075Results posted
- A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19CompletedNCT04649151Phase 2/3Results posted
- A Phase III Clinical Study to Evaluate SYN023's Efficacy and SafetyCompletedNCT04644484Phase 3Results posted
- Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory TractTerminatedNCT04633187Phase 2Results posted
- Study to Evaluate Efficacy and Safety of "VIRACIDE" IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)CompletedNCT04596085Not applicableResults posted
- A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus InfectionCompletedNCT04585789Phase 2Results posted
- Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in AdultsCompletedNCT04546724Phase 3Results posted
- First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.CompletedNCT04535167Phase 1Results posted
- Immune Responses With ReduxiumCompletedNCT04525456Not applicableResults posted
- Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory PathogensTerminatedNCT04431050Results posted
- Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)TerminatedNCT04409873Phase 2Results posted
- Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19)TerminatedNCT04382131Not applicableResults posted
- A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised AdultsCompletedNCT04380701Phase 1/2Results posted
- Convalescent Plasma Collection and Treatment in Pediatrics and AdultsCompletedNCT04376034Phase 3Results posted
- Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19TerminatedNCT04365101Phase 1/2Results posted
- COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) TrialCompletedNCT04354155Phase 2Results posted
- Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19TerminatedNCT04322396Phase 2Results posted
- Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral InfectionCompletedNCT04244084Phase 3Results posted
- Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy AdultsCompletedNCT04232280Phase 2Results posted
- Pilot of Cohort of Households for Influenza Monitoring and Evaluation in SeattleCompletedNCT04141930Phase 4Results posted
- Test-and-treat for Influenza in Homeless SheltersTerminatedNCT04141917Phase 4Results posted
- A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus InfectionCompletedNCT04129554Phase 2Results posted
- Phase 2a Respiratory Syncytial Virus (RSV) Human Challenge Study of Clesrovimab (MK-1654) in Healthy Participants (MK-1654-005)CompletedNCT04086472Phase 2Results posted
- Safety and Immunogenicity Study of QIVc in Healthy Pediatric SubjectsCompletedNCT04074928Phase 3Results posted
- A Two-Part Infant Study for Early Diagnosis of Respiratory Syncytial Virus (RSV) and Evaluation of JNJ-53718678 in RSV Acute Respiratory Tract DiseaseCompletedNCT04068792Phase 2Results posted
- Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV)TerminatedNCT04056611Phase 2Results posted
- Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus InfectionCompletedNCT04042740Phase 2Results posted
- Smell Changes & Efficacy of Nasal TheophyllineCompletedNCT03990766Phase 2Results posted
- A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus InfectionCompletedNCT03982186Phase 2Results posted
- A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital WartsCompletedNCT03981822Phase 2Results posted
- A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk ChildrenCompletedNCT03959488Phase 2/3Results posted
- A Study of 2-dose Vaccination Regimen of Ad26.ZEBOV and MVA-BN-Filo in InfantsCompletedNCT03929757Phase 2Results posted
- Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of AgeTerminatedNCT03916185Phase 1/2Results posted
- Donor-Derived Viral Specific T-cells (VSTs) for Prophylaxis Against Viral Infections After Allogeneic Stem Cell TransplantCompletedNCT03883906Phase 2Results posted
- A Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430CompletedNCT03800173Phase 1Results posted
- Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)TerminatedNCT03769467Phase 1/2Results posted
- A Study of RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus InfectionTerminatedNCT03762681Phase 1Results posted
- Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the ElderlyCompletedNCT03739112Phase 3Results posted
- Investigational Therapeutics for the Treatment of People With Ebola Virus DiseaseCompletedNCT03719586Phase 2/3Results posted
- Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral InfectionsCompletedNCT03707912Phase 4Results posted
- Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus InfectionTerminatedNCT03656510Phase 2Results posted
- Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG)CompletedNCT03624946Phase 1Results posted
- Cantharidin and Occlusion in Verruca EpitheliumCompletedNCT03487549Phase 2Results posted
- cAd3-Marburg Vaccine in Healthy AdultsCompletedNCT03475056Phase 1Results posted